These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6202036)

  • 1. Acute retention of urine due to benign prostatic obstruction treated with alpha-adrenergic blockers.
    Reuther K; Aagaard J
    Urol Int; 1984; 39(2):114-5. PubMed ID: 6202036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of alpha-adrenergic blockers in benign prostatic obstruction.
    Caine M; Pfau A; Perlberg S
    Br J Urol; 1976 Aug; 48(4):255-63. PubMed ID: 61054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute urinary retention secondary to benign prostatic hyperplasia. Effect of alpha-adrenergic blockade.
    Goodwin MI; Chester JF; Jenkins JD
    Urol Int; 1986; 41(6):430-1. PubMed ID: 2435043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of a serotonin antagonist ketanserin on acute urinary retention.
    Hørby J; Gyrtrup HJ; Frimodt-Møller C; Mathiesen FR
    Scand J Urol Nephrol; 1989; 23(2):121-2. PubMed ID: 2474193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of an alpha 1-adrenergic blocker (prazosin HCl) on micturition disturbances associated with benign prostatic hypertrophy.
    Shimizu K; Nakai K; Imai K; Yamanaka H
    Urol Int; 1990; 45 Suppl 1():36-9. PubMed ID: 1690479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Correction of urination disorders caused by benign prostatic hyperplasia in cardiac surgery].
    Koraev KN
    Khirurgiia (Mosk); 2003; (1):19-21. PubMed ID: 12645203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to daily 10 mg alfuzosin predicts acute urinary retention and benign prostatic hyperplasia related surgery in men with lower urinary tract symptoms.
    Emberton M; Lukacs B; Matzkin H; Alcaraz A; Elhilali M; Vallancien G
    J Urol; 2006 Sep; 176(3):1051-6. PubMed ID: 16890690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical study of bunazosin hydrochloride, an alpha 1-adrenergic blocker, in benign prostatic obstruction and neurogenic bladder dysfunction].
    Takita T; Kondo A; Mitsuya H; Otani T
    Hinyokika Kiyo; 1987 Sep; 33(9):1375-84. PubMed ID: 2449057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment by prostatic injection of acute urinary retention due to prostatic hyperplasia.
    Shipman JJ; Akilie AN
    Br Med J; 1967 May; 2(5549):418-9. PubMed ID: 4164447
    [No Abstract]   [Full Text] [Related]  

  • 10. [Uroselectivity of alpha-1 antagonism in the treatment of benign prostatic hypertrophy: on the pharmacologic concept of the clinical approach].
    Jolliet P; Bourin M
    Therapie; 1998; 53(1):61-6. PubMed ID: 9773101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of KT-611 (Naftopidil) on the contraction of human prostatic tissue and its use in benign prostatic obstruction].
    Yamanaka N; Yamaguchi O; Kameoka H; Fukaya Y; Yokota T; Shiraiwa Y; Yokoyama J; Kumakawa K; Itou K; Kuma Y
    Hinyokika Kiyo; 1991 Dec; 37(12):1759-72. PubMed ID: 1723843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary flow rate in benign prostatic hypertrophy.
    Anikwe RM
    Int Surg; 1976 Feb; 61(2):109-11. PubMed ID: 56317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experience in the use of doxazosin in patients with benign hyperplasia of the prostate].
    Lopatkin NA; Loran OB; Pushkar' DIu; Perepanova TS; Tevlin KP
    Urol Nefrol (Mosk); 1998; (3):3-5. PubMed ID: 9644978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of prazosin HCl on micturition disturbance associated with benign prostatic hypertrophy and bladder neck contracture.
    Kohama Y; Watanabe H; Sen Y; Yamamoto Y; Morioka M; Fujita Y
    Urol Int; 1990; 45 Suppl 1():26-9. PubMed ID: 1690477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Safety ov benign prostatic hyperplasia treatment with alpha-adrenoblocker dalphas].
    Loran OB; Pushkar' DIu; Rasner PI
    Urologiia; 2000; (2):3-5. PubMed ID: 11186726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural history of benign prostatic hypertrophy and acute urinary retention.
    Birkhoff JD; Wiederhorn AR; Hamilton ML; Zinsser HH
    Urology; 1976 Jan; 7(1):48-52. PubMed ID: 54971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of urinary retention due to benign prostatic hyperplasia using luteinizing hormone-releasing hormone agonist.
    Schlegel PN; Brendler CB
    Urology; 1989 Aug; 34(2):69-72. PubMed ID: 2474882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Generally effective for unstable bladder? Tamsulosin: application not limited to benign prostatic hyperplasia].
    Urologe A; 2003 Feb; 42(2):301-2. PubMed ID: 12739514
    [No Abstract]   [Full Text] [Related]  

  • 19. Prostatic and extraprostatic alpha-adrenoceptors--contributions to the lower urinary tract symptoms in benign prostatic hyperplasia.
    Andersson KE
    Scand J Urol Nephrol Suppl; 1996; 179():105-11. PubMed ID: 8908675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does the use of silodosin to treat benign prostatic hyperplasia really offer something new?
    Morgia G
    Eur Urol; 2011 Mar; 59(3):353-5; discussion 355. PubMed ID: 21130562
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.